Sr. Director TS/MS - Small Molecule - Lebanon API at Eli Lilly and Company

Lebanon, Indiana, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

Experience in technical services/manufacturing science (TS/MS) for small molecule API manufacturing
Leadership experience managing TS/MS functions, including capacity, capability, and leadership structures
Ability to provide administrative and technical leadership for small molecule TS/MS operations
Expertise in GMP manufacturing, process validation, and regulatory compliance (e.g., pre-approval inspections)
Knowledge of new product introduction, process optimization, and technical agenda development
Strategic planning and execution skills for site and business objectives
Experience building technical relationships with development groups (e.g., Synthetic Molecule Design and Development)
People management skills, including coaching, mentoring, resource allocation, and developing future technical leadership
Ability to manage cross-functional issues spanning multiple teams and external contexts

Responsibilities

Manage the site TS/MS function for small molecule API, ensuring capacity, capability, and leadership to execute the manufacturing plan
Serve as a member of the Lilly Lebanon API Small Molecule Plant Lead Team, contributing to strategic direction, organizational capability, and business management
Support safe, on-time startup, process validation, and successful pre-approval inspections
Develop and participate in medium- and long-term strategic direction for the site
Provide leadership for the small molecule technical agenda and support new molecule introductions
Develop future technical leadership for the plant, including for potential international assignments
Collaborate with Development groups to identify and pursue new products or business opportunities
Lead all aspects of small molecule TS/MS, including new product introduction and optimization
Participate in developing and executing strategic and operational plans for the site
Build technical relationships with Synthetic Molecule Design and Development organization
Participate in key strategic decisions for the small molecule business from planning and execution perspectives
Ensure all small molecule processes remain in a validated state, meeting cGMP and regulatory requirements
Ensure technical documents are up to date and technical reports are completed on schedule to appropriate standards
Provide necessary resources and facilities to the TS/MS business unit
Coach and mentor others in leadership, business, and technical areas, providing feedback and administrative support

Skills

GMP Manufacturing

API Production

Small Molecule

Technical Services

Manufacturing Science

Process Development

Greenfield Startup

Pharmaceutical Leadership

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free